EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis and Cuproptosis in Cancer and Neurodegeneration: A Comprehensive Review of Modulation by Iron and Copper Chelators and Related Agents

Iogann Tolbatov iD, Alessandro Marrone iD

Biomolecules · 26.02.2026 · 16 (3) · 348

DOI: 10.3390/biom16030348 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 26.02.2026. Verfasst von Iogann Tolbatov und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy. Hauptthemen laut MEDLINE: Ferroptosis, Cuproptosis, Copper, Chelating Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of iron and copper homeostasis is a pivotal driver of regulated cell death through two distinct yet interconnected modalities: ferroptosis and cuproptosis. This comprehensive review evaluates the therapeutic modulation of these metal-driven pathways within a dual paradigm: their deployment as a cytotoxic weapon in oncology and their inhibition for neuroprotection. We synthesize evidence ranging from small-molecule synergy to advanced nanomedicine, examining how the interplay between iron and copper governs cellular fate in resistant malignancies and neurodegenerative diseases such as Parkinson’s disease and Multiple Sclerosis. In oncology, bimetallic nanoplatforms and CRISPR-Cas9 nano-ionophores exploit “iron addiction” and metabolic vulnerabilities to induce fatal lipid peroxidation and FDX1-mediated proteotoxic stress, often by circumventing efflux transporters like ATP7A/B. Conversely, neuroprotective strategies focus on site-specific chelation, utilizing brain-penetrant molecules like SK4 (targeting the LAT1 transporter) and radical trapping antioxidants like CuII(atsm). Importantly, we elucidate the “iron trap” mechanism, where copper deficiency inactivates multicopper ferroxidases—including ceruloplasmin and hephaestin—thereby triggering iron-dependent ferroptosis. Our analysis reveals a self-amplifying cycle of oxidative damage driven by metal-induced ATP depletion and glutathione exhaustion. By delineating the molecular machinery of iron and copper metabolism, this article provides a roadmap for leveraging regulated cell death to overcome apoptosis resistance in cancer and preserve neural integrity in chronic degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCuproptosisCopperChelating AgentsNeoplasmsIronNeurodegenerative DiseasesHumansAnimalsIron Chelating Agents

Stichwörter der Autor:innen

cancercuproptosisferroptosismetal chelatorsneuroprotection

Substanzen

CopperChelating AgentsIronIron Chelating Agents

Autor:innen und Institutionen

  • Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy.
  • Department of Pharmacy, University "G. D'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.

ORCID-Profile: Iogann Tolbatov, Alessandro Marrone

Zitieren

APA

Tolbatov, I., & Marrone, A. (2026). Ferroptosis and Cuproptosis in Cancer and Neurodegeneration: A Comprehensive Review of Modulation by Iron and Copper Chelators and Related Agents. Biomolecules, 16(3), 348. https://doi.org/10.3390/biom16030348

Vancouver

Tolbatov I, Marrone A. Ferroptosis and Cuproptosis in Cancer and Neurodegeneration: A Comprehensive Review of Modulation by Iron and Copper Chelators and Related Agents. Biomolecules. 2026;16(3):348. doi:10.3390/biom16030348

BibTeX
@article{Tolbatov2026,
  author = {Tolbatov, Iogann and Marrone, Alessandro},
  title = {Ferroptosis and Cuproptosis in Cancer and Neurodegeneration: A Comprehensive Review of Modulation by Iron and Copper Chelators and Related Agents},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {348},
  doi = {10.3390/biom16030348}
}
Kostenlos starten →